Published in Cancer Weekly, September 28th, 2004
The principal investigator of the open-label, single-center trial is Hak Choy, MD, professor and chair of the Department of Radiation Oncology at the University of Texas Southwestern Medical Center, Dallas.
The initial, phase 1, portion of the trial,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.